Vichien Srimuninnimit

发表

FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

T. Mok, B. Karaszewska, K. Kubota, 2021 .